Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.
Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckier F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachia A, Friedlander G, Chrétien F, Simon-Loriere E, Gaillard R.
Plaze M, et al. Among authors: chiaravalli j.
Int J Antimicrob Agents. 2021 Mar;57(3):106274. doi: 10.1016/j.ijantimicag.2020.106274. Epub 2020 Dec 30.
Int J Antimicrob Agents. 2021.
PMID: 33387629
Free PMC article.